Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation

Molecular Carcinogenesis

Volumn 54, Issue 5, 2015, Pages 405-415

  Ding, Zongmei ^a   Liu, Xiancheng ^b   Liu, Yonghua ^b   Zhang, Jianguo ^b   Huang, Xianting ^b   Yang, Xiaojing ^b   Yao, Li ^b   Cui, Gang ^c   Wang, Donglin ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

C Myc; FBP1; Glioma; Prognosis; Proliferation

Indexed keywords

BINDING PROTEIN; FAR UPSTREAM ELEMENT BINDING PROTEIN 1; MYC PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; DNA HELICASE; FUBP1 PROTEIN, HUMAN; MESSENGER RNA; MYC PROTEIN, HUMAN;

ARTICLE; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BRAIN; BRAIN TUMOR; CANCER GRADING; CANCER STAGING; CELL CYCLE; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR CELL CULTURE;

APOPTOSIS; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; DNA HELICASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84926522830     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22114     Document Type: Article

References (32)

1. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 2007; 2121:2683-2710.
2. Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) 2009; 415:341-351.
3. Surawicz TS, Davis F, Freels S, Laws ER, Jr., Menck HR. Brain tumor survival: Results from the National Cancer Data Base. J Neurooncol 1998; 402:151-160.
4. Gabriely G, Yi M, Narayan RS, et al. Human glioma growth is controlled by microRNA-10b. Cancer Res 2011; 7110:3563-3572.
5. Avigan MI, Strober B, Levens D. A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. J Biol Chem 1990; 26530:18538-18545.
6. Duncan R, Bazar L, Michelotti G, et al. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 1994; 84:465-480.
7. Zheng Y, Miskimins WK. Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int J Biochem Cell Biol 2011; 4311:1641-1648.
8. Huang PN, Lin JY, Locker N, et al. Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res 2011; 3922:9633-9648.
9. Jang M, Park BC, Kang S, et al. Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene. Oncogene 2009; 2812:1529-1536.
10. Singer S, Malz M, Herpel E, et al. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res 2009; 696:2234-2243.
11. Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, et al. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology 2009; 504:1121-1129.
12. Weber A, Kristiansen I, Johannsen M, et al. The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer 2008; 8:369.
13. Zhang Z, Harris D, Pandey VN. The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus. J Virol 2008; 8212:5761-573.
14. Xie F, Liu H, Zhu YH, et al. Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 2011; 11:86.
15. Wierstra I, Alves J. The c-myc promoter: Still MysterY and challenge. Adv Cancer Res 2008; 99:113-333.
16. Zhang J, Chen QM. Far upstream element binding protein 1: A commander of transcription, translation and beyond. Oncogene 2012.
17. de Nigris F, Sica V, Herrmann J, et al. c-Myc oncoprotein: Cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle 2003; 24:325-328.
18. Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene 2008; 2750:6462-6472.
19. Levens D. Disentangling the MYC web. Proc Natl Acad Sci U S A 2002; 999:5757-5759.
20. Pelengaris S, Khan M, Evan G. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2002; 210:764-776.
21. Malz M, Weber A, Singer S, et al. Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells. Hepatology 2009; 504:1130-1139.
22. Morris GF, Mathews MB. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 1989; 26423:13856-13864.
23. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 2001; 1511:1311-1333.
24. He L, Liu J, Collins I, et al. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J 2000; 195:1034-1044.
25. Liu J, Kouzine F, Nie Z, et al. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J 2006; 2510:2119-2130.
26. Kim MJ, Park BJ, Kang YS, et al. Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation. Nat Genet 2003; 343:330-336.
27. Liu J, He L, Collins I, et al. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell 2000; 52:331-341.
28. Niforou KM, Anagnostopoulos AK, Vougas K, Kittas C, Gorgoulis VG, Tsangaris GT. The proteome profile of the human osteosarcoma U2OS cell line. Cancer Genomics Proteomics 2008; 51:63-78.
29. Engidawork E, Afjehi-Sadat L, Yang JW, Slavc I, Lubec G. Protein chemical identification and characterization of the human variants of far upstream element binding protein in medulloblastoma DAOY cell line. Int J Oncol 2006; 293:721-736.
30. Sahm F, Koelsche C, Meyer J, et al. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathol 2012; 123:853-860.
31. Bettegowda C, Agrawal N, Jiao Y, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011; 333:1453-1455.
32. Herms JW, von Loewenich FD, Behnke J, Markakis E, Kretzschmar HA. c-myc oncogene family expression in glioblastoma and survival. Surg Neurol 1999; 515:536-542.